News

NVE Corporation: Recovery And Dividend Payment, Both Sustainable
NVE Corporation combines strong margins, a 4.7% yield, and spintronics-driven growth with minimal tariff risk and solid cash ...
C&EN6d
Leveraging Structure-Based Drug Design to Identify Next-Generation MAT2A Inhibitors, Including Brain-Penetrant and Peripherally Efficacious Leads - ACS Publications
Inhibition of the S-adenosyl methionine (SAM)-producing metabolic enzyme, methionine adenosyltransferase 2A (MAT2A), has received significant interest in the field of medicinal chemistry due to its ...